Navigation Links
Medivation Announces Second Quarter 2008 Teleconference and Webcast on August 11, 2008
Date:8/4/2008

SAN FRANCISCO, Aug. 4 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN) today announced that it will host a teleconference and webcast with management to discuss second quarter 2008 progress and provide a general business update on Monday, August 11, 2008, at 4:30 p.m. Eastern time. A financial results press release for the second quarter ended June 30, 2008 will be released after markets close on August 11, 2008.

Interested parties may call 877-397-0286 from the U.S. or +1-719-325-4901 internationally. Individuals interested in listening to the live call via webcast may do so by visiting http://www.medivation.com. A replay of the webcast will be available on the Company's website for 30 days.

About Medivation

Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers. The Company's current clinical development program includes a pivotal and confirmatory Phase 3 trial of Dimebon in Alzheimer's disease and a Phase 1-2 clinical trial of MDV3100 in patients with castration-resistant (also known as hormone-refractory) prostate cancer. Medivation recently announced that it plans to continue further development of Dimebon in patients with mild-to-moderate Huntington's disease based on the positive results seen in its Phase 2 trial. For more information, please visit us at http://www.medivation.com.


'/>"/>
SOURCE Medivation, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Medivation Selected as Founding Member of New NASDAQ(R) NeuroInsights(R) Neurotech Index
2. Medivation Announces Participation in Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
3. Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
4. Medivation Announces Senior Management Promotions
5. Medivation Announces Presentation of Positive MDV3100 Clinical Data in Castration-Resistant Prostate Cancer Patients
6. Medivation Announces Presentation at the BMO Capital Markets 2008 Focus on Healthcare Conference on August 5
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
9. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
10. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
11. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)... ORCHARD PARK, N.Y., Nov. 20 /PRNewswire-FirstCal...nnounced effective today it will reduce its workfo..., Dave DiGiacinto, President and Chief Operating... necessary action to reduce our cost structure to ...se financial condition as we discussed in our rece...
(Date:11/20/2008)... , Innovative consumer li...liday gift for 2008. Now available through Dick,s ...Pittsburgh, PA (Vocus) November 20, 2008 -- BodyM... monitoring systems, today announced the launch of...ement system that helps consumers monitor their bo...
(Date:11/20/2008)... PLYMOUTH MEETING, Pa., Nov. 20 /PRNewswire-First... ) ("BMP Sunstone" or the "Company") today announc...ngshan) Pharmaceutical Co., Ltd,("Sunstone"), has..." a liquid-,filled hard capsule (LFHC) used to tr... entire LFHC filling and sealing production line, ...
(Date:11/20/2008)... LONGMONT, Colo., Nov. 20 MicroPh...ounced it has concluded its latest round,of finan...lion. Investors in,this round were a combination...e have come from private investors. , Micro...lete the validation,and launch preparation of the...
Breaking Biology Technology:MINRAD International, Inc. Announces Reduction in Workforce 2BodyMedia, Inc. Launches GowearFit, the First Direct-to-Consumer Lifestyle and Calorie Management System 2BodyMedia, Inc. Launches GowearFit, the First Direct-to-Consumer Lifestyle and Calorie Management System 3BMP Sunstone Acquires 'Runchang Capsule' and Related LFHC Technology 2BMP Sunstone Acquires 'Runchang Capsule' and Related LFHC Technology 3MicroPhage Closes Latest Financing 2
...traveled to an event in Madison, Wis. that was org...Network. It was designed to bring together three g...on: Madison, Milwaukee and of course Chicago. , ,...t the first to go on the road), the idea is derive...n come together to meet each other for a very quic...
...arket has been steadily advancing. People are star...olios once again. This is happening in spite of th...obs in the US are disappearing, and most will neve...ve years the US economy could be in real big troub...sing trade imbalances with countries such as China...
...ote: "FORWARD VISIONS" Today we begin three weeks...will appear on the Wisconsin Technology Network (W...gned to stimulate awareness, discussion and debate...oughts and technologies surrounding Wisconsin,s He...mber 1-7. WTN will publish EXCLUSIVE articles and ...
...must transition itself to the information age simi...ars ago to increase the productivity of our staff,... This transformation process is a considerable en...to look inward and understand how they operate and...e healthcare. , ,I will speak about my neck of the...
Other Biology Technology:Mike Rosen Reviews - eXtreme Networking in Madison 2Mike Rosen Reviews - eXtreme Networking in Madison 3The Next Economy - Market Collapses Drive Long-Term Growth 2Why Wisconsin Lags Behind the U.S. and Minnesota 2Why Wisconsin Lags Behind the U.S. and Minnesota 3Why Wisconsin Lags Behind the U.S. and Minnesota 4Why Wisconsin Lags Behind the U.S. and Minnesota 5Im Still Waiting for the Information Age in Healthcare 2Im Still Waiting for the Information Age in Healthcare 3
(Date:11/21/2008)..., , , , , , , ,...VIDEO: , Graduate student Sue Lynn Lau partic... is completing a PhD at Garvan Institute of Medica...tle of her... , , Click here for... , , , , , , , ...
(Date:11/21/2008)...f popular varieties of rice, which can withstand 2...in farmers, fields with flying colors. Several of ...by national and state seed certification agencies ...r crop losses because of flooding of up to 4 milli...eed 30 million people. , The flood-tolerant vers...
(Date:11/20/2008)...e becoming increasingly aware of toxic chemical ex...enol A in some baby bottles and lead in some toys,...oducts with personal chemical exposure and related...m the December issue of the Journal of Health and...e pollution with large-scale contamination and env...
(Date:11/20/2008)...cal Institute at St. Joseph,s Hospital and Medical...motions and the perception of illusory motion that...ik, PhD, director of the Laboratory of Behavioral ...tor of the Laboratory of Visual Neuroscience; Xoan...ted a study based on the Enigma painting, a visual...
Breaking Biology News(10 mins):The 2009 AAAS/Science dance contest winners are announced 2The 2009 AAAS/Science dance contest winners are announced 3The 2009 AAAS/Science dance contest winners are announced 4The 2009 AAAS/Science dance contest winners are announced 5The 2009 AAAS/Science dance contest winners are announced 6The 2009 AAAS/Science dance contest winners are announced 7From genes to farmers' fields 2From genes to farmers' fields 3Pollution at home lurks unrecognized, instead attributed to large-scale environmental disasters 2Federal Regulation Will Require Renovators to Work Safely with Lead Paint 15600 1Federal Regulation Will Require Renovators to Work Safely with Lead Paint 15600 2Federal Regulation Will Require Renovators to Work Safely with Lead Paint 15600 3Chem Rx Corporation Schedules Conference Call to Review Full Year 2007 Financial Results 4303 1Chem Rx Corporation Schedules Conference Call to Review Full Year 2007 Financial Results 4303 2Longevinex 28R 29 Found to be Superior to Green Tea Molecule in Independent Human Study 1648 1Longevinex 28R 29 Found to be Superior to Green Tea Molecule in Independent Human Study 1648 2Fatality rates increase with repeal of helmet laws MU study finds 15590 1Fatality rates increase with repeal of helmet laws MU study finds 15590 2
...e plague bacterium uses a single gene to out-fox i...arch published in the journal Proceedings of the N...that Photorhabdus bacteria produce an antibiotic w...immune systems use to defend themselves from attac...ractions are thought to be common in diseases, ver...
...rom magnetic resonance imaging (MRI) to computed t...and organs have become the primary tools physician... for effective treatment. , New, innovative data...sity will provide doctors with a dramatically impr...ommonly used. This patent-pending technology allow...
...ing symptoms cancer patients experience during che...ult for health care professionals to accurately as...ersity of Illinois at Chicago are studying fatigue...ts using a method successfully used to monitor beh... , The method is called "ecological momentary as...
...d possibly even more ?than humans do. , And remark...volutionary terms, it has many of the immune syste...ct, it is possible some of these were pioneered by...s in the world ?yet they may possess a set of gene...David Miller of the ARC Centre of Excellence in Co...
Other Biology News:Scientists discover rare 'gene-for-gene' interaction that helps bacteria kill their host 2Novel system developed to turn data into real-time, interactive 3-D images 2Cancer patients monitor fatigue in real time 2Corals -- More complex than you? 2Corals -- More complex than you? 3
Yields DNA greater than 50 kb in length from yeast, fungi, Gram neg. and Gram pos. bacteria
Anti-human L-Ficolin, Clone GN4, Monoclonal Antibody
B3GALT2 Immunogen: B3GALT2 (NP_003774, 324 a.a. ~ 423 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only
Rabbit polyclonal to ThPok ( Abpromise for all tested applications). Antigen: Synthetic peptide conjugated to KLH derived from within residues 500 to the C-terminus of Human ThPok. (Note: the a
Biology Products: